Literature DB >> 11271635

Midfacial granuloma syndrome or an inflammatory non-specific disease? A case report.

V Torre1, S Bucolo, B Galletti, V Cavallari.   

Abstract

We report a case of idiopathic midline destructive disease in a 57-year-old man. The patient had a non-specific histological pattern in biopsies obtained from the nose and upper lip, characterized by a granulomatous reaction with progressive destruction of the tissues. The patient's general medical history was non-contributory. Clinical and laboratory data did not support any feasible etiology for this destructive process. The patient was treated with prednisone until the discovery of type II diabetes mellitus (never diagnosed before) and was then in turn treated only with oral antidiabetic therapy. Follow-up controls revealed progressive reduction of the symptoms and of the nasal and lip lesions and total remission of symptoms up to 2 years after the onset of the disease. We discuss the diagnostic and subsequent therapeutic problems in the management of the midline necrotizing lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11271635     DOI: 10.1034/j.1600-0714.2001.300310.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

1.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17

Review 2.  Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

Authors:  Dong Ming Li; Li De Lun
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

3.  Case Report: Rhizopus arrhizus Rhino-Orbital-Cerebral Mycosis and Lethal Midline Granuloma: Another Fungal Etiological Agent.

Authors:  Dong Ming Li; Li De Lun; Jie Ge; Gong Jie Zhang; Xin Lun Li; G Sybren de Hoog
Journal:  Front Med (Lausanne)       Date:  2021-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.